UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$463M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$360M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$345M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$265M |
| 5 |
ConocoPhillips
COP
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$293M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$239M |
| 5 |
UnitedHealth
UNH
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.86% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Communication Services | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Carriage Services
CSV
$569M
| $831K | ﹤0.01% |
25,843
| – | – |
|
2027
Vaxcyte
PCVX
$8.64B
| $831K | ﹤0.01% |
34,628
+24,296
| +235% | +$616K |
|
2028
Riot Platforms
RIOT
$7.76B
| $831K | ﹤0.01% |
118,505
-10,199
| -8% | -$71.8K |
|
2029
NRC Health Common Stock
NRC
$450M
| $829K | ﹤0.01% |
20,824
+1,913
| +10% | +$70.8K |
|
2030
Ennis
EBF
$564M
| $826K | ﹤0.01% |
41,053
+9,946
| +32% | +$210K |
|
2031
Center Bancorp
CNOB
$1.78B
| $825K | ﹤0.01% |
35,774
-2,021
| -5% | -$51.6K |
|
2032
Mirion Technologies
MIR
$3.91B
| $821K | ﹤0.01% |
109,926
+10,626
| +11% | +$74.8K |
|
2033
Standard Motor Products
SMP
$911M
| $821K | ﹤0.01% |
25,251
-2,749
| -10% | -$109K |
|
|
BBBY
2034
Bed Bath & Beyond
BBBY
$442M
| $820K | ﹤0.01% |
37,045
-10,092
| -21% | -$253K |
|
2035
Hanmi Financial
HAFC
$946M
| $820K | ﹤0.01% |
34,626
+24,323
| +236% | +$597K |
|
2036
Recursion Pharmaceuticals
RXRX
$1.73B
| $818K | ﹤0.01% |
76,879
+25,426
| +49% | +$258K |
|
2037
Origin Bancorp
OBK
$1.66B
| $817K | ﹤0.01% |
21,244
| – | – |
|
2038
Ethan Allen Interiors
ETD
$603M
| $816K | ﹤0.01% |
38,613
+695
| +2% | +$16.2K |
|
2039
Usana Health Sciences
USNA
$286M
| $815K | ﹤0.01% |
14,544
+901
| +7% | +$59.6K |
|
|
SQSP
2040
DELISTED
Squarespace, Inc.
SQSP
| $814K | ﹤0.01% |
38,104
-196
| -0.5% | -$4.27K |
|
|
BRKL
2041
DELISTED
Brookline Bancorp
BRKL
| $813K | ﹤0.01% |
69,800
-24,486
| -26% | -$324K |
|
|
PTRA
2042
DELISTED
Proterra Inc. Common Stock
PTRA
| $813K | ﹤0.01% |
163,262
-17,099
| -9% | -$95.9K |
|
2043
Sotera Health
SHC
$5.38B
| $812K | ﹤0.01% |
119,085
-13,228
| -10% | -$220K |
|
|
AERI
2044
DELISTED
Aerie Pharmaceuticals
AERI
| $810K | ﹤0.01% |
53,554
+2,310
| +5% | +$26.9K |
|
2045
Modine Manufacturing
MOD
$10.4B
| $808K | ﹤0.01% |
62,475
-9,231
| -13% | -$130K |
|
2046
Utz Brands
UTZ
$1.25B
| $808K | ﹤0.01% |
53,511
-3,159
| -6% | -$51.2K |
|
|
MGI
2047
DELISTED
MoneyGram International, Inc. New
MGI
| $807K | ﹤0.01% |
77,598
+14,124
| +22% | +$146K |
|
2048
ACV Auctions
ACVA
$1.3B
| $804K | ﹤0.01% |
111,851
+35,476
| +46% | +$282K |
|
2049
Expro Ltd
XPRO
$1.91B
| $801K | ﹤0.01% |
+62,842
| New | +$762K |
|
2050
BioLife Solutions
BLFS
$1.7B
| $800K | ﹤0.01% |
35,143
-6,231
| -15% | -$133K |
|
Similar funds
UBS AM's Q3 2022 Portfolio in Review
As of Q3 2022, UBS AM held 2,816 positions worth $178B, down 6.6% from $191B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
UBS AM's Q3 2022 filing shows 65 new, 702 increased, 1,679 reduced and 77 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M. The largest sale was Apple, an estimated $2.03B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q3 2022 buy was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M.
- UBS AM added most to Accenture in Q3 2022, an estimated $463M increase.
- UBS AM's biggest Q3 2022 reduction was Apple, cutting an estimated $2.03B.
- UBS AM fully exited Vanguard Russell 1000 ETF in Q3 2022, selling an estimated $93.3M.
- UBS AM's ten largest holdings make up 21% of its $178B portfolio in Q3 2022.
- UBS AM opened 65 new positions and closed 77 in Q3 2022.
- UBS AM's portfolio value fell 6.6% quarter-over-quarter to $178B.
Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.